TLR9 and systemic lupus erythematosus: These results suggest that, at least partly because of the increased levels of PDGF-B coming from elevated TLR9/TGF-β1/PDGF-B pathway activation, plasma of SLE patients can promote mesangial cell proliferation significantly.